Adrenomedullin and endothelin-1 are associated with myocardial injury and death in septic shock patients

Oscar H M Lundberg, Lill Bergenzaun, Jörgen Rydén, Mari Rosenqvist, Olle Melander, Michelle S Chew, Oscar H M Lundberg, Lill Bergenzaun, Jörgen Rydén, Mari Rosenqvist, Olle Melander, Michelle S Chew

Abstract

Background: Adrenomedullin and endothelin-1 are hormones with opposing effects on the cardiovascular system. Adrenomedullin acts as a vasodilator and seems to be important for the initiation and continuation of the hyperdynamic circulatory response in sepsis. Endothelin-1 is a vasoconstrictor and has been linked to decreased cardiac performance. Few studies have studied the relationship between adrenomedullin and endothelin-1, and morbidity and mortality in septic shock patients. High-sensitivity troponin T (hsTNT) is normally used to diagnose acute cardiac injury but is also prognostic for outcome in intensive care. We investigated the relationship between mid-regional pro-adrenomedullin (MR-proADM), C-terminal pro-endothelin-1 (CT-proET-1), and myocardial injury, measured using transthoracic echocardiography and hsTNT in septic shock patients. We were also interested in the development of different biomarkers throughout the ICU stay, and how early measurements were related to mortality. Further, we assessed if a positive biomarker panel, consisting of MR-proADM, CT-proET-1, and hsTNT changed the odds for mortality.

Methods: A cohort of 53 consecutive patients with septic shock had their levels of MR-proADM, CT-proET-1, hsTNT, and left ventricular systolic functions prospectively measured over 7 days. The relationship between day 1 levels of MR-proADM/CT-proET-1 and myocardial injury was studied. We also investigated the relationship between biomarkers and early (7-day) and later (28-day) mortality. Likelihood ratios, and pretest and posttest odds for mortality were calculated.

Results: Levels of MR-proADM and CT-proET-1 were significantly higher among patients with myocardial injury and were correlated with left ventricular systolic dysfunction. MR-proADM and hsTNT were significantly higher among 7-day and 28-day non-survivors. CT-proET-1 was also significantly higher among 28-day but not 7-day non-survivors. A positive biomarker panel consisting of the three biomarkers increased the odds for mortality 13-fold to 20-fold.

Conclusions: MR-proADM and CT-proET-1 are associated with myocardial injury. A biomarker panel combining MR-proADM, CT-proET-1, and hsTNT increases the odds ratio for death, and may improve currently available scoring systems in critical care.

Keywords: Adrenomedullin; Echocardiography; Endothelin-1; High-sensitivity troponin; Likelihood ratio; Mortality; Myocardial injury; Sepsis; Shock.

Figures

Fig. 1
Fig. 1
Temporal development of MR-proADM, CT-proET-1 and hsTNT

References

    1. Samson WK, Resch ZT, Murphy TC, Vargas TT, Schell DA. Adrenomedullin: Is There Physiological Relevance in the Pathology and Pharmacology? News Physiol Sci. 1999;14:255–9.
    1. Lainchbury JG, Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG. Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers. J Clin Endocrinol Metab. 2000;85(3):1016–20.
    1. Nicholls MG, Lainchbury JG, Lewis LK, McGregor DO, Richards AM, Troughton RW, et al. Bioactivity of adrenomedullin and proadrenomedullin N-terminal 20 peptide in man. Peptides. 2001;22(11):1745–52. doi: 10.1016/S0196-9781(01)00508-3.
    1. Temmesfeld-Wollbruck B, Brell B, David I, Dorenberg M, Adolphs J, Schmeck B, et al. Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock. Intensive Care Med. 2007;33(4):703–10. doi: 10.1007/s00134-007-0561-y.
    1. Hippenstiel S, Witzenrath M, Schmeck B, Hocke A, Krisp M, Krull M, et al. Adrenomedullin reduces endothelial hyperpermeability. Circ Res. 2002;91(7):618–25. doi: 10.1161/01.RES.0000036603.61868.F9.
    1. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem. 2005;51(10):1823–9. doi: 10.1373/clinchem.2005.051110.
    1. Guignant C, Voirin N, Venet F, Poitevin F, Malcus C, Bohe J, et al. Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients. Intensive Care Med. 2009;35(11):1859–67. doi: 10.1007/s00134-009-1610-5.
    1. Galie N, Manes A, Branzi A. The endothelin system in pulmonary arterial hypertension. Cardiovasc Res. 2004;61(2):227–37. doi: 10.1016/j.cardiores.2003.11.026.
    1. Papassotiriou J, Morgenthaler NG, Struck J, Alonso C, Bergmann A. Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma. Clin Chem. 2006;52(6):1144–51. doi: 10.1373/clinchem.2005.065581.
    1. Hochholzer W, Morrow DA, Giugliano RP. Novel biomarkers in cardiovascular disease: update 2010. Am Heart J. 2010;160(4):583–94. doi: 10.1016/j.ahj.2010.06.010.
    1. Bergenzaun L, Ohlin H, Gudmundsson P, During J, Willenheimer R, Chew MS. High-sensitive cardiac Troponin T is superior to echocardiography in predicting 1-year mortality in patients with SIRS and shock in intensive care. BMC Anesthesiol. 2012;12:25. doi: 10.1186/1471-2253-12-25.
    1. Lim W, Qushmaq I, Devereaux PJ, Heels-Ansdell D, Lauzier F, Ismaila AS, et al. Elevated cardiac troponin measurements in critically ill patients. Arch Intern Med. 2006;166(22):2446–54. doi: 10.1001/archinte.166.22.2446.
    1. McLean AS, Huang SJ. Cardiac biomarkers in the intensive care unit. Ann Intensive Care. 2012;2:8. doi: 10.1186/2110-5820-2-8.
    1. Reynolds T, Cecconi M, Collinson P, Rhodes A, Grounds RM, Hamilton MA. Raised serum cardiac troponin I concentrations predict hospital mortality in intensive care unit patients. Br J Anaesth. 2012;109(2):219–24. doi: 10.1093/bja/aes141.
    1. Lim W, Whitlock R, Khera V, Devereaux PJ, Tkaczyk A, Heels-Ansdell D, et al. Etiology of troponin elevation in critically ill patients. J Crit Care. 2010;25(2):322–8. doi: 10.1016/j.jcrc.2009.07.002.
    1. Rosjo H, Varpula M, Hagve TA, Karlsson S, Ruokonen E, Pettila V, et al. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med. 2011;37(1):77–85. doi: 10.1007/s00134-010-2051-x.
    1. Furian T, Aguiar C, Prado K, Ribeiro RV, Becker L, Martinelli N, et al. Ventricular dysfunction and dilation in severe sepsis and septic shock: relation to endothelial function and mortality. J Crit Care. 2012;27(3):319. doi: 10.1016/j.jcrc.2011.06.017.
    1. Miguel D, Prieto B, Costa M, Coto D, Alvarez FV. Cord blood plasma reference intervals for potential sepsis markers: pro-adrenomedullin, pro-endothelin, and pro-atrial natriuretic peptide. Clin Biochem. 2011;44(4):337–41. doi: 10.1016/j.clinbiochem.2010.12.012.
    1. Pittet JF, Morel DR, Hemsen A, Gunning K, Lacroix JS, Suter PM, et al. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg. 1991;213(3):261–4. doi: 10.1097/00000658-199103000-00014.
    1. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–228. doi: 10.1007/s00134-012-2769-8.
    1. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(3):858–73. doi: 10.1097/01.CCM.0000117317.18092.E4.
    1. Brouwers FP, de Boer RA, van der Harst P, Struck J, de Jong PE, de Zeeuw D, et al. Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population. Heart. 2012;98(18):1348–53. doi: 10.1136/heartjnl-2012-302390.
    1. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56(2):254–61. doi: 10.1373/clinchem.2009.132654.
    1. Bergenzaun L, Gudmundsson P, Ohlin H, During J, Ersson A, Ihrman L, et al. Assessing left ventricular systolic function in shock: evaluation of echocardiographic parameters in intensive care. Crit Care. 2011;15(4):R200. doi: 10.1186/cc10368.
    1. Khan SQ, O’Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, et al. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol. 2007;49(14):1525–32. doi: 10.1016/j.jacc.2006.12.038.
    1. Maisel A, Mueller C, Nowak RM, Peacock WF, Ponikowski P, Mockel M, et al. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol. 2011;58(10):1057–67. doi: 10.1016/j.jacc.2011.06.006.
    1. Wang P, Ba ZF, Cioffi WG, Bland KI, Chaudry IH. The pivotal role of adrenomedullin in producing hyperdynamic circulation during the early stage of sepsis. Arch Surg. 1998;133(12):1298–304. doi: 10.1001/archsurg.133.12.1298.
    1. Shindo T, Kurihara H, Kurihara Y, Morita H, Yazaki Y. Upregulation of endothelin-1 and adrenomedullin gene expression in the mouse endotoxin shock model. J Cardiovasc Pharmacol. 1998;31(Suppl 1):S541–4. doi: 10.1097/00005344-199800001-00156.
    1. Wang P. Andrenomedullin and cardiovascular responses in sepsis. Peptides. 2001;22(11):1835–40. doi: 10.1016/S0196-9781(01)00534-4.
    1. Ertmer C, Morelli A, Rehberg S, Lange M, Hucklenbruch C, Van Aken H, et al. Exogenous adrenomedullin prevents and reverses hypodynamic circulation and pulmonary hypertension in ovine endotoxaemia. Br J Anaesth. 2007;99(6):830–6. doi: 10.1093/bja/aem295.
    1. Fowler DE, Wang P. The cardiovascular response in sepsis: proposed mechanisms of the beneficial effect of adrenomedullin and its binding protein (review) Int J Mol Med. 2002;9(5):443–9.
    1. Wagner K, Wachter U, Vogt JA, Scheuerle A, McCook O, Weber S, et al. Adrenomedullin binding improves catecholamine responsiveness and kidney function in resuscitated murine septic shock. Intensive Care Med Exp. 2013;1(1):21. doi: 10.1186/2197-425X-1-2.
    1. Struck J, Hein F, Karasch S, Bergmann A. Epitope specificity of anti-Adrenomedullin antibodies determines efficacy of mortality reduction in a cecal ligation and puncture mouse model. Intensive Care Med Exp. 2013;1(1):22. doi: 10.1186/2197-425X-1-3.
    1. Muller-Redetzky HC, Will D, Hellwig K, Kummer W, Tschernig T, Pfeil U, et al. Mechanical ventilation drives pneumococcal pneumonia into lung injury and sepsis in mice: protection by adrenomedullin. Crit Care. 2014;18(2):R73. doi: 10.1186/cc13830.
    1. Wanecek M, Weitzberg E, Rudehill A, Oldner A. The endothelin system in septic and endotoxin shock. Eur J Pharmacol. 2000;407(1-2):1–15. doi: 10.1016/S0014-2999(00)00675-0.
    1. Wanecek M, Oldner A, Sundin P, Alving K, Weitzberg E, Rudehill A. Effects on haemodynamics by selective endothelin ET(B) receptor and combined endothelin ET(A)/ET(B) receptor antagonism during endotoxin shock. Eur J Pharmacol. 1999;386(2-3):235–45. doi: 10.1016/S0014-2999(99)00774-8.
    1. Goto T, Hussein MH, Kato S, Daoud GA, Kato T, Kakita H, et al. Endothelin receptor antagonist attenuates inflammatory response and prolongs the survival time in a neonatal sepsis model. Intensive Care Med. 2010;36(12):2132–9. doi: 10.1007/s00134-010-2040-0.
    1. Krzeminski K, Pawlowska-Jenerowicz W. The relationships between plasma adrenomedullin and endothelin-1 concentrations and Doppler echocardiographic indices of left ventricular function during static exercise in healthy men. J Hum Kinet. 2012;33:81–9. doi: 10.2478/v10078-012-0047-z.
    1. Li K, Stewart DJ, Rouleau JL. Myocardial contractile actions of endothelin-1 in rat and rabbit papillary muscles. Role of endocardial endothelium. Circ Res. 1991;69(2):301–12. doi: 10.1161/01.RES.69.2.301.
    1. Kramer BK, Smith TW, Kelly RA. Endothelin and increased contractility in adult rat ventricular myocytes. Role of intracellular alkalosis induced by activation of the protein kinase C-dependent Na(+)-H+ exchanger. Circ Res. 1991;68(1):269–79. doi: 10.1161/01.RES.68.1.269.
    1. Wanecek M, Weitzberg E, Alving K, Rudehill A, Oldner A. Effects of the endothelin receptor antagonist bosentan on cardiac performance during porcine endotoxin shock. Acta Anaesthesiol Scand. 2001;45(10):1262–70. doi: 10.1034/j.1399-6576.2001.451015.x.
    1. Fenhammar J, Andersson A, Forestier J, Weitzberg E, Sollevi A, Hjelmqvist H, et al. Endothelin receptor A antagonism attenuates renal medullary blood flow impairment in endotoxemic pigs. PLoS One. 2011;6(7):e21534. doi: 10.1371/journal.pone.0021534.
    1. Konrad D, Haney M, Johansson G, Wanecek M, Weitzberg E, Oldner A. Cardiac effects of endothelin receptor antagonism in endotoxemic pigs. Am J Physiol Heart Circ Physiol. 2007;293(2):H988–96. doi: 10.1152/ajpheart.01023.2006.
    1. Brauner JS, Rohde LE, Clausell N. Circulating endothelin-1 and tumor necrosis factor-alpha: early predictors of mortality in patients with septic shock. Intensive Care Med. 2000;26(3):305–13. doi: 10.1007/s001340051154.
    1. Schuetz P, Christ-Crain M, Morgenthaler NG, Struck J, Bergmann A, Muller B. Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium. 2007;14(6):345–51. doi: 10.1080/10623320701678326.
    1. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Muller B. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care. 2005;9(6):R816–24. doi: 10.1186/cc3885.
    1. Ueda S, Nishio K, Minamino N, Kubo A, Akai Y, Kangawa K, et al. Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am J Respir Crit Care Med. 1999;160(1):132–6. doi: 10.1164/ajrccm.160.1.9810006.
    1. Hagag AA, Elmahdy HS, Ezzat AA. Prognostic value of plasma pro-adrenomedullin and antithrombin levels in neonatal sepsis. Indian Pediatr. 2011;48(6):471–3. doi: 10.1007/s13312-011-0074-1.
    1. Guignant C, Venet F, Voirin N, Poitevin F, Malcus C, Bohe J, et al. Proatrial natriuretic peptide is a better predictor of 28-day mortality in septic shock patients than proendothelin-1. Clin Chem Lab Med. 2010;48(12):1813–20. doi: 10.1515/CCLM.2010.341.
    1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020–35. doi: 10.1161/CIR.0b013e31826e1058.
    1. Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how? BMJ. 2009;338:b375. doi: 10.1136/bmj.b375.
    1. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–70. doi: 10.1093/ehjci/jev014.
    1. Matos J, Kronzon I, Panagopoulos G, Perk G. Mitral annular plane systolic excursion as a surrogate for left ventricular ejection fraction. J Am Soc Echocardiogr. 2012;25(9):969–74. doi: 10.1016/j.echo.2012.06.011.
    1. Elnoamany MF, Abdelhameed AK. Mitral annular motion as a surrogate for left ventricular function: correlation with brain natriuretic peptide levels. Eur J Echocardiogr. 2006;7(3):187–98. doi: 10.1016/j.euje.2005.05.005.
    1. Chahal NS, Lim TK, Jain P, Chambers JC, Kooner JS, Senior R. Normative reference values for the tissue Doppler imaging parameters of left ventricular function: a population-based study. Eur J Echocardiogr. 2010;11(1):51–6. doi: 10.1093/ejechocard/jep164.
    1. Alam M, Wardell J, Andersson E, Samad BA, Nordlander R. Effects of first myocardial infarction on left ventricular systolic and diastolic function with the use of mitral annular velocity determined by pulsed wave doppler tissue imaging. J Am Soc Echocardiogr. 2000;13(5):343–52. doi: 10.1016/S0894-7317(00)70003-4.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する